Immuneering recently announced positive initial Phase 2a data, including complete and partial responses, with IMM-1-104 in combination with chemotherapy in first-line pancreatic cancer patients ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune disease.

You want to make things clear right from the get-go: for which devices can your chosen studio develop an application for? Do they specialise in iOS, Android or crossplatform (apps that work on both ...